Overview
INJ and VSN rarely move in perfect sync. Today’s print ($5.01/$1,856.75) and 24h leaders (Injective) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | INJ | VSN |
|---|---|---|
| Price | $5.01 | $1,856.75 |
| Market Cap | $490.41M | $134.35M |
| FDV | — | — |
| Volume 24h | $2.77M | $1.16M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 209.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | VSN |
|---|---|---|
| 1H | — | — |
| 24H | +2.04% | -0.70% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | VSN |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.07 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 67.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight neutral conditions on INJ and bearish on VSN. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | INJ | VSN |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
VSN
Pros and cons
Pros of Injective
- Injective has an established coin page footprint on PEPS for continuous monitoring.
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
Cons of Injective
- Regulatory or macro headlines can hit Injective harder simply because it is more visible.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
Pros of VSN
- Diversifying versus Injective with VSN can change portfolio factor exposure.
- Narrative optionality around VSN can reprice quickly when catalysts appear.
- VSN can offer higher relative beta when market attention rotates toward its niche.
Cons of VSN
- Trend failures on VSN often travel faster than on more established assets.
- Weaker market-cap standing may leave VSN more exposed to liquidity droughts.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Smaller book depth versus large caps can increase slippage for VSN.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
For readers asking which is “better”, the honest answer is conditional. Injective and VSN solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, Injective or VSN?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or VSN?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and VSN.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.